Addiction 2021 | Webinar | | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Advanced Scientific Research For Addiction, Mental Health And Rehabilitation

- Addiction 2021

About Conference

The 3rd International Conference on Addiction Research and Therapy is designed under the theme '' Advanced Scientific Research for Addiction, Mental Health, and Rehabilitation '' to show the latest trends in Addiction Science.

The key motto of Addiction Conferences 2021 is to unite like-minded individuals to mold the future of research that will shape the world. Addiction Conferences 2023 will redraft your brain with new techniques and innovations which will help to boost self-esteem and confidence.

The Addiction Conferences 2021 will feature scientific research on the latest developments which will include 15+ keynote speeches, 50+ invited talks, and 100+ technical papers and it's going to be a huge platform with more than 300 global participants.

It is an initiative to eradicate addiction by empowering addiction recovery and its therapy. While many of the brain tissues that are caused by addiction and substance abuse cannot be reversed completely, this gathering will be the best place to search out the latest research and learn how to manage the symptoms of addiction that may facilitate people accomplish its recovery.

It is a platform to join hands with the strongest scientific community to have a closer look at what is involved in addiction therapy and research by exploring new prospects and increasing the existing opportunities.

Welcome Message

Welcome the global crowd to Addiction 2021!

The Addiction Committee is honored and privileged to welcome all addiction professionals to attend our most remarkable conference the 3rd International Conference on Addiction Research and Therapy which transpires on October 08-09, 2021, as a Webinar.

After five spectacular and successful editions, we eagerly anticipate bringing together the worldwide audience and attendees once again to discuss ideas, solutions, and success stories. This year, we forecast more participants to exchange their valuable knowledge with an indigenous theme of "Advanced Scientific Research for Addiction, Mental Health, and Rehabilitation".

The Addiction 2021 is widely renowned for providing you with a platform to engage with individuals from all around the world, who are dedicated to their profession in researching addiction and helping individuals achieve recovery and return to their best fruitful lives possible.

Addiction 2021 is projected to be a massive event that provides an excellent stage for sharing knowledge on modern technology in addiction recovery.

Addiction is a chronic disease; it becomes progressive when left untreated. We are also committed to raising awareness about addictive drugs and their treatment based on their symptoms in Addiction Conferences 2023.

We enthusiastically welcome all researchers around the globe working on Addiction, which includes Professors, Doctors, Addiction Counsellors, Addiction Therapists, Addiction Psychiatrists, Addiction Specialists, Mental Health Specialists, Psychotherapists, Clinical Psychiatrists, Psychologists, Psychiatrists, Students, Graduates, Academicians, All Rehabilitation Nurses, and Addiction Rehabilitation Centres are invited to come and share their thoughts.

It's a fascinating opportunity for everyone to enable international networking and interact with world-class experts. Be a part of addiction therapy and recovery by working cooperatively with us. Share your research experiences and expertise on the subject at our conference to help accelerate future innovation in order to establish and celebrate a new healthier world.

We really appreciate your time and effort in cooperating with Addiction 2021.

Scientific Sessions

Session1: Addiction and Addiction Medicine

Addiction Treatment is set to register lucrative gains from 2022 to 2028 impelled by growing incidences of substance abuse including tobacco, alcohol, and drugs. The excessive consumption of these substances is known to cause debilitating damage to the human body.

Chronic Mental Illness
Epigenetic Mechanisms in Addiction
Abstinence-based Treatment
Reflective System Impairment
Addiction Nursing
Stimulants and Depressants
Drug withdrawal

Session 2: Therapies on Addiction

At present, apart from tobacco addiction, the global number of alcohol and drug addiction cases continue to move in the upward trajectory due to which, the demand for addiction treatment is increasing. In the current scenario, the adoption of new technological advancements such as telecommuting within the healthcare sector is on the rise. At present, the number of collaborations between application developers and healthcare experts is growing at a rapid pace and the trend is expected to continue during the forecast period.

Drug Therapy
Psychotherapy
Psychodynamic Therapy
Motivational Enhancement Therapy
Motivational Interviewing
EMDR therapy

Session 3: Addiction Recovery Treatment

Drug abuse and addiction is a growing epidemic at the forefront of public health. Within this remit, the illicit use of opioid analgesics alone has emerged as one of the fastest growing forms of drug abuse in the U.S. and the death rate from this epidemic are drawing comparison to the US AIDS epidemic. Traditional methods of epidemiology based on explicit reporting of indicator-based data from patient records or data collected through surveys is often found wanting in modelling and designing effective interventions for addiction.

Deep Brain Stimulation (DBS) for addiction Recovery
Residential Treatment
Outpatient Treatment
Day Treatment/Partial Hospitalization
Sober Living Communities

Session 4: Addiction Rehabilitation

The global medical rehabilitation services market size was valued at USD 144.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2022 to 2030. Medical rehabilitation services help in faster recovery, prevention, and management of injuries and chronic conditions, which is anticipated to bolster market growth. Patients suffering from conditions such as musculoskeletal, neurological, and cardiologic conditions usually benefit from rehabilitation services. The general intent is to enable the patient to confront substance dependence and cease substance abuse to avoid the psychological causes, especially by extreme abuse.

Warm and Cold Turkey Treatment for Heroin Rehabilitation
Residential Drug Rehabilitation Program
Inpatient Rehab
Outpatient Rehab
Alcohol Detoxification
Drug Detoxification
Metabolic Detoxification
Alternative Medicine

Session 5: Addiction Counselling

Dealing with addiction can be a long and arduous journey. That is what makes the role of rehabilitation counselors so important. Addictions counselors work for many different kinds of entities and organizations, including rehabilitation facilities, mental health centers, community organizations and prisons. Some work in private practice. Addictions counselors have the chance to make a true impact on the well-being of others and can play a critical role in turning around the lives of those struggling with these problems

Twelve-Step Facilitation (TSF)
Group Therapy
Family & Couples Therapy
Cognitive Behavioural Therapy (CBT)
Dialectical Behavioural Therapy (DBT)
Contingency Management

Session 6: Psychosis in Addiction

Psychosis is generally distinguished as the impaired relationship the person faces with reality where they are not aware of the behavior caused by their abnormal thinking and perceptions. At present, the global psychotic disorder treatment market accounts for US$ 13.6 billion and is projected to surge past a valuation of US$ 24.5 billion by the end of 2032. Stress levels among the general population have increased notably over the past few years and this has led to an increase in the incidence of psychotic disorders such as bipolar disorder, schizophrenia, etc.

Hallucination
Delusion
Illusions
Psycho-Dynamic Therapy
Psychology and Education
Disorganization
Perceptual Disorders
Alogia
Substance-Induced Psychotic Disorder
Antidepressants
Chemotherapy Drugs

Session 7: Addictive Disorders

Substance abuse and dependence are the common disorders that come to our minds when we hear about the addictive disorder. The United States Addiction Disorders Drugs Market size was estimated at USD 4,590.08 million in 2021, USD 5,124.32 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.15% to reach USD 7,347.77 million by 2027..

Attention Deficit Hyperactivity Disorder (ADHD)
Anxiety Disorder
Bipolar Disorder
Borderline Personality Disorder
Obsessive-Compulsive Disorder
Post-Traumatic Stress Disorder (PTSD)
Sexual Disorder
Sleep Disorder
Neurological Disorders caused by Substance Abuse

Session 8: Behavioral Addiction

The latest business intelligence studies dictate that the global behavioral disorders rehabilitation market is anticipated to record an outstanding growth rate of 4.8 % during the forecast period of 2017 to 2025. It also projects that the global behavioral rehabilitation market will surpass the final evaluation of US$ 313.9 billion by the end of the forecast period in 2025. Some of the major drivers for the global behavioral rehabilitation market include the presence of favorable initiatives by governments across the world, the increasing number of service providers, and the rising levels of awareness pertaining to these diseases in the global population.

Cell Phone and Social Media Addiction
Gambling Addiction
Food Addiction
Internet Addiction
Pornography

Session 9: Psychiatry and Mental Health

The global mental health market was valued at $383.31 billion in 2020 and is estimated to reach $537.97 billion by 2030, growing at a CAGR of 3.5% from 2021 to 2030. Mental health problems are characterized by the absence of positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 individuals. The factors such as genes as well as stress and brain chemistry lead to depression. According to the WHO, more than 264 million people of all ages suffered from depression in 2020. Depression is a leading cause of disability worldwide and is a major contributor to the overall global burden of disease.

Psychiatric Genetics
Psychiatric Epidemiology
Neuropsychiatry
Mental Disorder
Psychoanalysis
Addiction Psychiatry
Epilepsy
Child & Adolescent Psychiatry
Clinical Psychology

Session 10: Traditional Approaches to Addiction

In 2014, an estimated 21.4 million people in the United States who were 12 years old or older battled a substance use disorder, which equates to about 1 in every 12 American adults, the National Survey on Drug Use and Health (NSUDH) reported. The Yoga Journal describes modern yoga as the use of physical postures to learn how to connect mind, body, and breath to gain self-awareness and focus attention inward. According to data published by US News & World Report, around 21 million Americans practice yoga, a number that has doubled in the past 10 years.

Yoga Practice for Addictive Mind
Dance and Music Therapies
Natural Physio-therapeutic Methods
Retreat Facilities and Relapse
Psychology and Group Therapies
Ayurveda Treatment for Addiction
Multidimensional Family Therapy

Session 11: Drug Addiction

The global drug of abuse testing services market size was valued at USD 2.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2021 to 2028. An increase in the consumption of alcohol and illicit drugs has led to the high growth of the market. The rise in government initiatives to monitor and combat substance abuse is also significantly driving the market. According to the United Nations Office on Drugs and Crime (UNODC) 2019 data, around 35 million people with substance use disorders were in need of treatment globally. Around 55% of the substance use disorders are associated with opioids and 25% with marijuana

Harm Reduction Psychotherapy
Alcohol Addiction
E-Cigarette Addiction
Fentanyl Addiction
Heroin Addiction
Dissociative Drugs
Club Drugs (MDMA, Flunitrazepam, GHB)

Session 12: Drug Abuse

The cannabis/marijuana segment dominated the overall market in 2020 with a share of 26.0%. This can be attributed to the fact that marijuana or cannabis is the most commonly used illicit drug in the world. According to the Substance Abuse and Mental Health Services Administration, in 2018, the most commonly used illicit drug in the U.S. was marijuana, which was used by about 43.5 million people. Based on drug type, the market is segmented into alcohol, cannabis/marijuana, cocaine, opioids, amphetamine and methamphetamine, LSD, and others.

Nicotine Addiction
Tobacco Addiction
Cocaine Addiction
Opioids Addiction
Cannabinoids (Marijuana)
Benzo diazepine Abuse
Methamphetamine

Session 13: Substance Addiction

The opioids segment accounted for the second-largest share in 2020. This can be attributed to the increasing opioid crisis in key regions, such as North America and Europe. As per data published by the National Center for Drug Abuse Statistics, in 2018, around 2 million people in the U.S. had opioid use disorder (including heroin abuse and prescription pain reliever). Furthermore, key players in the market are undertaking organic growth strategies to expand their opioids testing portfolio.

Substance Abuse
HIV and Substance Use
Amphetamines
Prescription Drugs
Phencyclidine
Inhalants
Steroids
Synthetic Cannabinoids
Synthetic Cathinones

Session 14: Addiction Pharmacology

Addiction Pharmacology makes the recovery process easier by easing the side effects and cravings associated with withdrawal. The global $1.12 trillion market in 2022, will rise at a faster clip during 2016-2020, then slow down a bit as major patent expiration take hold. It is expected that the global market declined by 1.0% in 2015 but will grow by 4.8% this year. Prescription sales excluding generics will rise 4.4% this year and expected to reach $1.006 trillion in 2022. Generics sales will increase from $73 billion in 2015 to $115 billion in 2022 and constitute 10.2% of prescription sales at that point only 0.3 percentage points more than it is now.

Drug Addiction and Consequences
Drug Receptors
Drug Tolerance
Drug Dependence
Drugs and their effects on Addiction
Pharmacotherapy

Session 15: Dual Diagnosis

Dual Diagnosis typically refers to a person with a mental disorder, co-occurring developmental disability, and substance abuse disorder. In 2017, psychology disorders visits & Consultations are expected to make up 30.3% of total Value revenue. This product Segment includes prevention services (12.4%), As well as consultation & diagnostic services (13.2%).

Dual Diagnosis Treatment
Clinical Diagnosis of Depression
Autism Diagnosis
Alzheimer’s Diagnosis
Schizophrenia Diagnosis
Anxiety Diagnosis
OCD Diagnosis
Multiaxial Diagnosis
Cerebral Palsy Diagnosis
Trigeminal Neuralgia Diagnosis
Peripheral Neuropathy Diagnosis
PDD Diagnosis
MDD Diagnosis
Dyspraxia Diagnosis
Dysautonomia Diagnosis

Session 16: Neuro-Toxicology

Neurotoxicity damages the brain and the peripheral nervous system, which is exposure to natural or man-made toxic substances. The global toxicology testing market size was estimated at USD 22.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10.7% from 2021 to 2028. Significant advancements in toxicology science are one of the primary factors driving the market. Also, high costs associated with conventional tests and socio-ethical concerns associated with laboratory tests are anticipated to boost the growth of the market for in-vitro toxicology testing.

Cognitive Neuroscience
Nervous System and Behavioural Toxicology
Neurotoxic Effects of Pharmaceutical Agents
Neurologic and Psychiatric Disorders
Parkinson's and Dyskinesia

Session 17: Addiction-induced Brain Disease

The brain disease market is expected to garner considerable growth across the forecast period of 2020-2030. The growing cases of brain-related diseases and disorders across the globe may bring tremendous growth prospects for the global brain disease market through the assessment period of 2020-2030. Furthermore, the study pays attention to the effect of the SARS-CoV-2 pandemic and also on the dangers that may hurt the growth of the brain disease market. The analysis by the researchers also highlights the opportunities and challenges that the brain disease market is anticipated to face between 2020 and 2030.

Diagnostic and Statistical Manual of Mental Disorders
Neuro-Cognitive Responses
Depression and Anxiety Disorders
Memory Loss and Hormones Instability
Brain Imaging Studies of Addictive Substances
Hallucinogens and Persisting Perception Disorder
Stimulants and Anhedonia
Dementia
Impulse Control Disorders
Intermittent Explosive Disorder
Kleptomania
Pyromania

Session 18: CNS Addictive Disorders

The global central nervous system therapeutic market size was valued at 116.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.4% from 2021 to 2028. Advancements in diagnostics and therapeutics of central nervous system (CNS) diseases are expected to increase the treatment rate globally. Moreover, the increasing prevalence of central nervous system disorders and the rising demand for effective therapeutics options are expected to boost market growth over the forecast years. The addictive drugs anticipate the nerves in the mind by secreting dopamine a joy chemical that affects their CNS normal function.

Drugs Affecting the Brain and CNS
Advances in Neurology of Substance Use
Neurological and Behavioral Changes
Gamma-Aminobutyric Acid (GABA)
Norepinephrine

Market Analysis

Market Analysis:

Based on geography, the addiction treatment market report covers data points from multiple geographies. The global market for addiction treatment reached USD 4.7 billion in 2021 and should reach nearly $7.4 billion in 2025, at a compound annual growth rate (CAGR) of 7.0% and roughly 6.0% over the next five years, will reach 8020 million USD in 2025, from 5540 million USD in 2021. According to the latest information collected about 40.5 million individuals aged 12 or older were using illicit drugs. This equates to roughly 14.2% of people aged 12 or older. Of those who admitted to having used illicit drugs, approximately 28 million people used marijuana, 4.2 million people abused prescription pain relievers, and 3.2 million people used cocaine. The released survey results suggest more than one-third (38.9%) of those diagnosed with alcohol dependence go on to “fully recover” the following year. These are all of the understanding that the situation currently helps with the path for an addiction treatment organization and discernment of this contest situation from the market.

Target Audience:

Addictologist, Addiction Therapist, Addiction Psychiatrist, Addiction Counsellor, Addiction Specialist, Clinical Psychiatrist, Psychiatrist, Psychologist, Psychotherapist, Mental Health Specialist, Neurotoxic Researchers, Addiction Association, Addiction Society, Addiction University, Addiction Rehab Centre, Addiction Laboratory, Addiction Researcher, Addiction Professors, Scientist, Doctors, Delegates, Students, Graduates, Young Researchers